INVAGEN PHARMS FDA Approval ANDA 090284

ANDA 090284

INVAGEN PHARMS

FDA Drug Application

Application #090284

Application Sponsors

ANDA 090284INVAGEN PHARMS

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL10MG0ALFUZOSIN HYDROCHLORIDEALFUZOSIN HYDROCHLORIDE

FDA Submissions

ORIG1AP2012-01-17
LABELING; LabelingSUPPL4AP2015-01-13STANDARD
LABELING; LabelingSUPPL5AP2015-01-13STANDARD

Submissions Property Types

ORIG1Null15
SUPPL4Null7
SUPPL5Null7

TE Codes

001PrescriptionAB

CDER Filings

INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90284
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALFUZOSIN HYDROCHLORIDE","activeIngredients":"ALFUZOSIN HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ALFUZOSIN HYDROCHLORIDE","submission":"ALFUZOSIN HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.